RAVOCAINE AND NOVOCAIN W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ravocaine And Novocain W, and when can generic versions of Ravocaine And Novocain W launch?
Ravocaine And Novocain W is a drug marketed by Eastman Kodak and is included in one NDA.
The generic ingredient in RAVOCAINE AND NOVOCAIN W is levonordefrin; procaine hydrochloride; propoxycaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; procaine hydrochloride; propoxycaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RAVOCAINE AND NOVOCAIN W?
- What are the global sales for RAVOCAINE AND NOVOCAIN W?
- What is Average Wholesale Price for RAVOCAINE AND NOVOCAIN W?
Summary for RAVOCAINE AND NOVOCAIN W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | RAVOCAINE AND NOVOCAIN W at DailyMed |
US Patents and Regulatory Information for RAVOCAINE AND NOVOCAIN W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eastman Kodak | RAVOCAINE AND NOVOCAIN W/ LEVOPHED | norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride | INJECTABLE;INJECTION | 008592-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eastman Kodak | RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN | levonordefrin; procaine hydrochloride; propoxycaine hydrochloride | INJECTABLE;INJECTION | 008592-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
